Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
Před 678 dny
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
Před 945 dny
Asian Shares Mostly Higher On Trade Deal Optimism
Asian stocks ended mostly higher on Monday as hopes of Fed rate cuts as well as easing tensions in the Middle East helped boost investors' appetite for riskier assets.
RTTNews
|
Před 17 minutami
Safe-Haven JPY Rises As Trader's Remain Cautious
The safe haven Japanese yen strengthened against other major currencies in the pre-European session on Monday, as traders remain cautious amid renewed optimism about new trade deals after U.S. President Donald Trump indicated he does not think he will need to extend the July 9 deadline for countries to secure trade deals with the US. Trump also indicated the U.S. had signed an agreement with China.
RTTNews
|
Před 1 h 31 min
Yen Rises Against Majors
The Japanese yen strengthened against other major currencies in the pre-European session on Monday.
RTTNews
|
Před 2 h 20 min
European Shares Seen Broadly Higher At Open
European stocks are seen opening broadly higher on Monday after Wall Street wrapped up last week with a powerful rally on trade deal and Fed rate cut hopes.
RTTNews
|
Před 3 h 17 min
European Economic News Preview: Germany Inflation & Retail Sales Data Due
Flash inflation and retail sales from Germany and revised GDP and mortgage approvals from the UK are due on Monday, headlining a hectic day for the European economic news. At 2.00 am ET, Destatis publishes Germany's import prices and retail sales figures. Retail sales are forecast to grow 0.5 percent month-on-month in May, in contrast to the 1.1 percent fall in April.
RTTNews
|
Před 3 h 22 min
Sensex, Nifty Subdued After Last Week's Rally
Indian shares were subdued on Monday after rising sharply last week, buoyed by receding tensions in the Middle East and a sharp correction in global crude oil prices.
RTTNews
|
Před 4 h 14 min
